(Q39344418)

11 September 2017

title

Gabapentin in patients with the pruritus of cholestasis: a double-blind, randomized, placebo-controlled trial (English)

1 reference

11 September 2017

0 references

0 references

Nora V Bergasa

1

1 reference

11 September 2017

Monnie McGee

series ordinal

2

1 reference

11 September 2017

Iona H Ginsburg

series ordinal

3

1 reference

11 September 2017

Danielle Engler

series ordinal

4

1 reference

11 September 2017

language of work or name

English

0 references

publication date

1 November 2006

1 reference

11 September 2017

1 reference

11 September 2017

volume

44

1 reference

11 September 2017

issue

5

1 reference

11 September 2017

page(s)

1317-1323

1 reference

The Structured Clinical Interview for DSM-III-R (SCID). II. Multisite test-retest reliability

11 September 2017

cites work

1 reference

Effects of naloxone infusions in patients with the pruritus of cholestasis. A double-blind, randomized, controlled trial

21 January 2018

1 reference

The pruritus of cholestasis

21 January 2018

1 reference

7 January 2021

The pruritus of cholestasis

1 reference

7 January 2021

Gabapentin reverses mechanical allodynia induced by sciatic nerve ischemia and formalin-induced nociception in mice.

1 reference

7 January 2021

Pharmacological characterisation of the rat brachial plexus avulsion model of neuropathic pain.

1 reference

7 January 2021

A rating scale for depression

1 reference

7 January 2021

A controlled trial of naloxone infusions for the pruritus of chronic cholestasis

1 reference

7 January 2021

Open-label trial of oral nalmefene therapy for the pruritus of cholestasis

1 reference

7 January 2021

Oral nalmefene therapy reduces scratching activity due to the pruritus of cholestasis: a controlled study

1 reference

7 January 2021

The placebo response: its putative role as a functional salutogenic mechanism of the central nervous system

1 reference

7 January 2021

Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease

1 reference

7 January 2021

Oral naltrexone treatment for cholestatic pruritus: A double-blind, placebo-controlled study

1 reference

7 January 2021

Liver transplantation for intractable pruritus is contraindicated before an adequate trial of opiate antagonist therapy

1 reference

7 January 2021

Efficacy and safety of oral naltrexone treatment for pruritus of cholestasis, a crossover, double blind, placebo-controlled study

1 reference

7 January 2021

The inhibition of epidural morphine-induced pruritus by epidural droperidol.

1 reference

7 January 2021

Thalamic relay nuclei of the basal ganglia form both reciprocal and nonreciprocal cortical connections, linking multiple frontal cortical areas.

1 reference

7 January 2021

Urge to scratch represented in the human cerebral cortex during itch

1 reference

7 January 2021

Central activation by histamine-induced itch: analogies to pain processing: a correlational analysis of O-15 H2O positron emission tomography studies

1 reference

7 January 2021

Imaging of central itch modulation in the human brain using positron emission tomography

1 reference

7 January 2021

Inhibition by GABA, baclofen and gabapentin of dopamine release from rabbit caudate nucleus: are there common or different sites of action?

1 reference

7 January 2021

Effect of gabapentin-like compounds on development and maintenance of morphine-induced conditioned place preference

1 reference

7 January 2021

Placebo-induced changes in FMRI in the anticipation and experience of pain

1 reference

7 January 2021

Opiate antagonist therapy for the pruritus of cholestasis: the avoidance of opioid withdrawal-like reactions

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.21370

1 reference

11 September 2017

1 reference